Autopsy report · NCT01234285
Safety of Heparin in Patients With Septic Shock
Cause of deathStaffing, sites or logistics
“Sara Cheng, MD has left the Univ. of Colorado and the study has been closed.”
Life of this trial
- Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.
Vital statistics
- Status
- Withdrawn
- Phase
- Phase 2
- Sponsor
- University of Colorado, Denver
- Sponsor type
- University, hospital or other
- Conditions
- Sepsis
- Interventions
- heparin; heparin; heparin; heparin
- Participants
- 0
- Sites
- 1
- Countries
- United States
Trials that died the same way
- Changes in Bone Turnover With Increased Incretin Hormone Exposure
“Study closed by sponsor. Funding ended.” - Sodium Thiosulfate Otoprotection During Salvage Cisplatin Therapy
“This study will be closing at CCHMC and may be transferred to a principal investigator at another insitutiton.” - Treosulfan-Based Versus Clofarabine-Based Conditioning Before Donor Hematopoietic Stem Cell Transplant for the Treatment of Myelodysplastic Syndromes or Acute Myeloid Leukemia
“The study was closed due to the end of funding.” - Therapeutic Exercise in Patients With Hemophilia
“The Study was terminated due to lack of funding for continuing” - Modafinil-Alcohol Interactions in Healthy Volunteers
“This study should be terminated as the study closed prior to 2007 and the investigator has since retired. No records are available.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.